Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -3270.86% is 139% below its 5-year average of -1371.27%, near the high end of its 5-year range (-30547.37%–0.00%).
24.55% below its 12-month average of -2626.24%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-3270.86%
OPERATING MARGIN AVG TTM
-2626.24%
OPERATING MARGIN AVG 3Y
-2285.44%
OPERATING MARGIN AVG 5Y
-1371.27%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-24.55%
CURRENT VS 3Y AVG
-43.12%
CURRENT VS 5Y AVG
-138.53%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 850 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Rallybio Corporation
Market Cap
$90.32M
Operating Margin
-3270.86%
TTM Avg
-2626.24%
3Y Avg
-2285.44%
5Y Avg
-1371.27%
Market Cap
$90.74M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$89.78M
Operating Margin
0.00%
TTM Avg
-10.06%
3Y Avg
-113.57%
5Y Avg
-75.71%
Market Cap
$89.33M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$89.26M
Operating Margin
-37.64%
TTM Avg
-44.68%
3Y Avg
-118.22%
5Y Avg
-258.09%
Market Cap
$88.60M
Operating Margin
7.31%
TTM Avg
8.88%
3Y Avg
-4.43%
5Y Avg
-3.84%
Market Cap
$88.45M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$92.33M
Operating Margin
-2.82%
TTM Avg
2.49%
3Y Avg
2.00%
5Y Avg
2.00%
Market Cap
$88.21M
Operating Margin
12.60%
TTM Avg
-0.11%
3Y Avg
-11.38%
5Y Avg
-8.86%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rallybio Corporation (RLYB) | $90.32M | -3270.86% | -2626.24% | -2285.44% | -1371.27% |
| Biomea Fusion, Inc. (BMEA)vs › | $90.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Equillium, Inc. (EQ)vs › | $89.78M | 0.00% | -10.06% | -113.57% | -75.71% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| electroCore, Inc. (ECOR)vs › | $89.26M | -37.64% | -44.68% | -118.22% | -258.09% |
| CareCloud, Inc. (CCLD)vs › | $88.60M | 7.31% | 8.88% | -4.43% | -3.84% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $88.45M | 0.00% | 0.00% | 0.00% | 0.00% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $92.33M | -2.82% | 2.49% | 2.00% | 2.00% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 12.60% | -0.11% | -11.38% | -8.86% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $86.09M | 29.69% | -17.51% | -923.94% | -894.93% |
Gross Margin
89.3%
Operating Margin
-3270.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | -2232.55% |
| 2025-12-31 | -2888.29% |
| 2025-09-30 | -3266.51% |
| 2025-06-30 | -4743.87% |
| 2025-03-31 | -4561.32% |
| 2024-12-31 | -30547.37% |
| 2024-09-30 | -4035.45% |
| 2024-06-30 | -5697.32% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
